Quantifying and Predicting the Effect of Exogenous Interleukin-7 on CD4+T Cells in HIV-1 Infection

PLoS Computational Biology

Volumn 10, Issue 5, 2014, Pages

  Thiébaut, Rodolphe ^a,b,c   Drylewicz, Julia ^d,e   Prague, Mélanie ^a,b,c   Lacabaratz, Christine ^f,g   Beq, Stéphanie ^h   Jarne, Ana ^a,b,c   Croughs, Thérèse ^h   Sekaly, Rafick Pierre ⁱ   Lederman, Michael M ^j   Sereti, Irini ^k   Commenges, Daniel ^a,b,c   Lévy, Yves ^f,g,l  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INRIA   (France)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

^f INSERM U955   (France)

^g UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^h Cytheris   (France)

ⁱ Vaccine and Gene Therapy Institute   (United States)

^j UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^k NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^l HENRI MONDOR HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; PATIENT TREATMENT;

ANTIRETROVIRALS; CD4 T-CELLS; HIV-1 INFECTIONS; INFECTED PATIENTS; INTERLEUKIN-7; MATHEMATICAL ANALYSIS; MEASUREMENTS OF; MECHANISM OF ACTION; POTENTIAL MECHANISM; REPEATED MEASUREMENTS;

T-CELLS;

CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; INTERLEUKIN 7; KI 67 ANTIGEN; IL7 PROTEIN, HUMAN;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; GLYCOSYLATION; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; BIOLOGICAL MODEL; CELL CULTURE; COMPUTER SIMULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PATHOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COMPUTER SIMULATION; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-7; KI-67 ANTIGEN; MODELS, IMMUNOLOGICAL;

EID: 84901660865     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003630     Document Type: Article

References (61)

1. Lange CG, Lederman MM, (2003) Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. Journal of Antimicrobial Chemotherapy 51: 1-4.
2. Fry TJ, Mackall CL, (2002) Interleukin-7: from bench to clinic. Blood 99: 3892-3904.
3. Mackall CL, Fry TJ, Gress RE, (2011) Harnessing the biology of IL-7 for therapeutic application. Nature Reviews Immunology 11: 330-342.
4. Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, et al. (2001) IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97: 1491-1497.
5. Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K, (1996) Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88: 1887-1894.
6. Okamoto Y, Douek DC, McFarland RD, Koup RA, (2002) Effects of exogenous interleukin-7 on human thymus function. Blood 99: 2851-2858.
7. Soares MV, Borthwick NJ, Maini MK, Janossy G, Salmon M, et al. (1998) IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. Journal of Immunology 161: 5909-5917.
8. Swainson L, Kinet S, Mongellaz C, Sourisseau M, Henriques T, et al. (2007) IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway. Blood 109: 1034-1042.
9. Sportes C, Hakim FT, Memon SA, Zhang H, Chua KS, et al. (2008) Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. Journal of Experimental Medicine 205: 1701-1714.
10. Fry TJ, Christensen BL, Komschlies KL, Gress RE, Mackall CL, (2001) Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood 97: 1525-1533.
11. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, et al. (2001) IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proceedings of the National Academy of Sciences of the United States of America 98: 8732-8737.
12. Vella AT, Dow S, Potter TA, Kappler J, Marrack P, (1998) Cytokine-induced survival of activated T cells in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 95: 3810-3815.
13. Seddon B, Tomlinson P, Zamoyska R, (2003) Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nature Immunology 4: 680-686.
14. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, et al. (2003) Interleukin 7 regulates the survival and generation of memory CD4 cells. Journal of Experimental Medicine 198: 1797-1806.
15. Leone A, Rohankhedkar M, Okoye A, Legasse A, Axthelm MK, et al. (2010) Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses. Journal of Immunology 185: 1650-1659.
16. Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, et al. (2001) A potential role for interleukin-7 in T-cell homeostasis. Blood 97: 2983-2990.
17. Mastroianni CM, Forcina G, d'Ettorre G, Lichtner M, Mengoni F, et al. (2001) Circulating levels of interleukin-7 in antiretroviral-naive and highly active antiretroviral therapy-treated HIV-infected patients. HIV Clinical Trials 2: 108-112.
18. Beq S, Delfraissy JF, Theze J, (2004) Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential. European Cytokine Network 15: 279-289.
19. Rajasuriar R, Booth D, Solomon A, Chua K, Spelman T, et al. (2010) Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor alpha and microbial translocation. The Journal of Infectious Diseases 202: 1254-1264.
20. Hodge JN, Srinivasula S, Hu Z, Read SW, Porter BO, et al. (2011) Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance. Blood 118: 3244-3253.
21. Guimond M, Veenstra RG, Grindler DJ, Zhang H, Cui Y, et al. (2009) Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nature Immunology 10: 149-157.
22. Shive CL, Mudd JC, Funderburg NT, Sieg SF, Kyi B, et al. (2014) Inflammatory Cytokines Drive CD4 T cell Cycling and Impaired Responsiveness to Interleukin-7: Implications for Immune Failure in HIV Disease. Journal of Infectious Diseases [Epub ahead of print]: doi: 10.1093/infdis/jiu125.
23. Zeng M, Smith AJ, Wietgrefe SW, Southern PJ, Schacker TW, et al. (2011) Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. Journal of Clinical Investigation 121: 998-1008.
24. Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, et al. (2010) Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. Journal of Virology 84: 96-108.
25. Beq S, Nugeyre MT, Ho Tsong Fang R, Gautier D, Legrand R, et al. (2006) IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. Journal of Immunology 176: 914-922.
26. Fry TJ, Moniuszko M, Creekmore S, Donohue SJ, Douek DC, et al. (2003) IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 101: 2294-2299.
27. Sereti I, Dunham RM, Spritzler J, Aga E, Proschan MA, et al. (2009) IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 113: 6304-6314.
28. Levy Y, Lacabaratz C, Weiss L, Viard JP, Goujard C, et al. (2009) Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. Journal of Clinical Investigation 119: 997-1007.
29. Camargo JF, Kulkarni H, Agan BK, Gaitan AA, Beachy LA, et al. (2009) Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression. The Journal of Infectious Diseases 199: 1872-1882.
30. Levy Y, Sereti I, Tambussi G, Routy J-P, Lelievre JD, et al. (2012) Effects of Recombinant Human Interleukin 7 on T Cell Recovery and Thymic Output in HIV-infected Patients receiving antiretroviral therapy: results of a Phase I/IIa Randomized, Placebo Controlled, Multicenter Study. Clinical Infectious Diseases 55: 291-300.
31. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, et al. (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695.
32. Bains I, Thiebaut R, Yates AJ, Callard R, (2009) Quantifying thymic export: combining models of naive T cell proliferation and TCR excision circle dynamics gives an explicit measure of thymic output. Journal of Immunology 183: 4329-4336.
33. Ribeiro RM, Mohri H, Ho DD, Perelson AS, (2002) In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4(+) but not CD8(+) T cells depleted? Proceedings of the National Academy of Sciences of the United States of America 99: 15572-15577.
34. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, et al. (1999) Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Medicine 5: 83-89.
35. Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, et al. (2001) Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. Journal of Experimental Medicine 194: 1731-1741.
36. Bains I, Antia R, Callard R, Yates AJ, (2009) Quantifying the development of the peripheral naive CD4+ T-cell pool in humans. Blood 113: 5480-5487.
37. den Braber I, Mugwagwa T, Vrisekoop N, Westera L, Mogling R, et al. (2012) Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 36: 288-297.
38. Abrams D, Levy Y, Losso MH, Babiker A, Collins G, et al. (2009) Interleukin-2 therapy in patients with HIV infection. The New England Journal of Medicine 361: 1548-1559.
39. Weiss L, Letimier FA, Carriere M, Maiella S, Donkova-Petrini V, et al. (2010) In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients. Proceedings of the National Academy of Sciences of the United States of America 107: 10632-10637.
40. Porter BO, Shen J, Kovacs JA, Davey RT, Rehm C, et al. (2009) Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels. AIDS 23: 2015-2019.
41. Reynolds J, Coles M, Lythe G, Molina-Paris C, (2013) Mathematical Model of Naive T Cell Division and Survival IL-7 Thresholds. Frontiers in Immunology 4: 434.
42. Vivien L, Benoist C, Mathis D, (2001) T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo. International immunology 13: 763-768.
43. Storek J, Gillespy T 3rd, Lu H, Joseph A, Dawson MA, et al. (2003) Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys. Blood 101: 4209-4218.
44. Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, et al. (2004) Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21: 289-302.
45. Mazzucchelli R, Durum SK, (2007) Interleukin-7 receptor expression: intelligent design. Nature Reviews in Immunology 7: 144-154.
46. Sereti I, Estes JD, Thompson WL, Morcock DR, Fischl MA, et al. (2014) Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathogens 10: e1003890.
47. Huang M, Sharma S, Zhu LX, Keane MP, Luo J, et al. (2002) IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. The Journal of Clinical Investigation 109: 931-937.
48. Meier D, Bornmann C, Chappaz S, Schmutz S, Otten LA, et al. (2007) Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 26: 643-654.
49. Onder L, Narang P, Scandella E, Chai Q, Iolyeva M, et al. (2012) IL-7-producing stromal cells are critical for lymph node remodeling. Blood 120: 4675-4683.
50. Beq S, Rozlan S, Gautier D, Parker R, Mersseman V, et al. (2009) Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques. Blood 114: 816-825.
51. Li J, Huston G, Swain SL, (2003) IL-7 promotes the transition of CD4 effectors to persistent memory cells. Journal of Experimental Medicine 198: 1807-1815.
52. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, et al. (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nature Medicine 15: 893-U892.
53. Prague M, Commenges D, Thiebaut R, (2013) Dynamical models of biomarkers and clinical progression for personalized medicine: The HIV context. Advanced Drug Delivery Review 65: 954-965.
54. Westera L, Zhang Y, Tesselaar K, Borghans JA, Macallan DC, (2013) Quantitating lymphocyte homeostasis in vivo in humans using stable isotope tracers. Methods in Molecular Biology 979: 107-131.
55. Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Sereti I, et al. (2005) Induction of prolonged survival of CD4(+) T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. Journal of Clinical Investigation 115: 2139-2148.
56. Scholzen T, Gerdes J, (2000) The Ki-67 protein: from the known and the unknown. Journal of Cell Physiology 182: 311-322.
57. Rosenbaum SE (2011). Basic pharmacokinetics and pharmacodynamics: an integrated textbook and computer simulations. First edition ed: Wiley & Sons, Hoboken New Jersey. pp. 352-356.
58. Drylewicz J, Commenges D, Thiébaut R, (2012) on behalf of the CASCADE Collaboration (2012) Maximum a Posteriori estimation in dynamical models of primary HIV infection. Statistical Communications in Infectious Diseases 4DOI: 10.1515/1948-4690.1040.
59. Prague M, Commenges D, Guedj J, Drylewicz J, Thiébaut R, (2013) NIMROD: A Program for Inference via Normal Approximation of the Posterior in Models with Random effects based on Ordinary Differential Equations. Computer Methods and Programs in Biomedicine 111: 447-458.
60. Hindmarsh AC, (1983) ODEPACK, A Systematized Collection of ODE Solvers. IMACS Transactions on Scientific Computation 1: 55-64.
61. Kass RE, Steffey D, (1989) Approximate Bayesian inference in conditionally independent hierarchical models (parametric empirical Bayes models). Journal of the American Statistical Association 84: 717-726.